Elephant In The Room

Mid Session

… It’s Already Here

Nearly simultaneously, all three YouTube channels that are monitored closely, have shifted their focus.

This phenomenon, instant change among disparate parties, has been well documented in the science community (before that community became corrupt) with animals on separate continents.

In short, it was found that herds of animals would instantly change their behavior to be congruent with each other even though there was no direct visible or physical connection.

It’s sort of a ‘collective consciousness’ phenomenon.

The YouTube presenters being discussed are:

I Allegedly

Jerimiah Babe

Texas Silver

Dan (I Allegedly) has literally thousands upon thousands of contacts. He’s an invaluable source of information.

He also has the stamina to sit through a Fed speech, Senate or Congressional hearings and the like … then report on what’s being discussed.

Jerimiah Babe gives us ‘boots on the ground’ reporting about the economic collapse so that we can see it for ourselves.

Texas Silver has the warrior mentality (and is not some coward ‘poser’ with useless crap all over his AR), showing us a working homestead and all that’s involved.

Their instantaneous shift in direction is being highlighted; not the importance of their channels which remains at the high end.

From a physical standpoint (like the animals separated by continents) they are not physically connected to each other.

Pulling Away From Precious Metals

Yet, all three have pulled away (in varying degrees) from the ‘stacking’ mentality.

Admittedly, Dan was never really a stacker … but he has changed direction; now talking about procuring supplies, food, water, medicines.

Be aware, there may be yet another collective shift (this time, world-wide) on the horizon.

Festering in the background, is an event that won’t be able to be ignored or dismissed as ‘conspiracy’ much longer .

It’s important to get out in front (if you aren’t already) and position oneself accordingly.

Which brings us to the elephant.

Biotech, SPBIO:

That elephant is, we’re at the front end of a potential mass genocide event (that’s already underway).

Conditions are already set in motion for a loss of the world-wide population of at least 5% – 10%, in the next 2, to 5 years (and that’s probably very conservative).

The chief cook and bottle washer in all of this, is biotech.

LABD (3X Inverse SPBIO):

Several charts are below. The vertical scale has been compressed to show the potential of the nascent move:

Today is the last trading day of the third quarter.

SPBIO, is on track to post lower three quarters in a row. No other major index is in the same position.

It seems to be taking forever but the case against biotech continues to build.

Positioning:

No doubt we’re short this sector via LABD (not advice not a recommendation), in a big way.

LABD has apparently finished its downward testing.

Now, as discussed (here and here), price action is alternating to the upside.

With that in mind, the new daily high of yesterday has not yet been reversed. This is alternating action when compared to the daily high reversal of September 20th.

Stay Tuned

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

When It Gets … Tight

Early Session

Tight Price Action … Trade About To Happen

We’ve got the daily chart of LABD, leveraged inverse fund Biotech, SPBIO, above.

Next, we highlight the tight price action and note the failed push lower:

Scroll up and down between the two charts and you can see, this is an area where the market has firmed-up.

Tight action is usually (not always) a pre-cursor of an upcoming move. One side is taking control; about to take the market their direction.

Note: The last two days (including today) show a pivot of sorts … still very young.

Positioning:

The tight stop on the DRV position was hit early in the session. Exit was performed at DRV 4.4336 (not advice, not a recommendation).

That freed-up capital was then allocated to a position in LABD (again, not advice, not a recommendation).

The stop is tight at LABD 18.79.

Stay Tuned

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

‘Fed – Fake’

After The Close

One-Way Before

Opposite-Way After

As is typical of Fed announcements, the market tends to go one way before the speech … then, the opposite way after the speech.

As real estate (IYR) pushed higher before the speech, it got just a little too far upward for comfort. The short position was closed out for one managed account.

As time progressed, price action was clearly setting up a spring condition; seen in the 30-minute leveraged inverse fund DRV, above.

The Project Stimulus Account closed its TZA position (for profit, table to follow) and the account then positioned long DRV, at about 4.49 (not advice, not a recommendation).

The stop is tight … the low of the day @ 4.42 (not advice, not a recommendation)

We’ll see what happens next

Stay Tuned

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

Knock Three Times …

Gold, GDX Warning: Breakdown Imminent?

It’s true when price action rebounds off a level, whether support or resistance, that level is confirmed.

However, personal (mental) bias, like the rabid hyperinflation ‘dollar destruction’ gold bulls, collectively have their minds so twisted, every bounce off so called support, is a buying opportunity.

That kind of blindness can set oneself up for (financial) disaster.

Well, we’re about to see if the current bounce was a buying opportunity or harbinger of a “free fall” breakdown.

Price action’s the final say. So, let’s take a look at what its been saying about the latest move.

Un-marked weekly chart of Senior Mining (ETF) Index GDX:

Next, comes the support line and contact points identified:

Now, comes the important part. Each rebound off support has less upward travel than before:

The right-most green arrow (upward travel), may or may not be complete. One fact in favor of completion is the significant amount of resistance around GDX, 33.00.

Price action has spent six weeks transacting in this area. Three weeks above support and now three weeks below.

Positioning:

We’re at the danger point; risk of being wrong on a short position is least (not advice, not a recommendation).

At this juncture, price action does not need to go far to either support or negate a short trade set-up.

With that in mind, the Project Stimulus account is short this sector via DUST (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

Dollar Destruction? Not Yet

Before The Open

‘Dollar Destruction’ To Be Postponed

Hyper-Inflation Not In The Charts

Who looks at the actual chart anyway … so old-school.

However, what that school is telling us, the dollar’s built a solid base for a sustained rally.

Then we have this: Uneducated Economist gives us links in his report on why dollar demand could increase substantially.

If dollars are going up, gold is going down.

At this juncture, there’s still an inverse correlation.

Position Update:

On a separate but related note, the FDA announcement from yesterday was not taken into account with the biotech plan. An error if you will.

The level of malfeasance as detailed in this link was not thought to be possible.

The Project Stimulus account exited the short biotech trade with a small gain as shown below.

More analysis to come on a potential long-term biotech reversal set-up not unlike the dollar.

For now, we’re out.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

‘Greed is Good’

11:53 a.m., EST

Old Fashioned Greed Saves The Day?

After BA pilot fatalities were confirmed, at least one airline is backing off from insisting their pilots are injected.

Some adverse reactions linked above, occurred in-flight; the pilot was incapacitated.

“Is there a pilot on-board?”

That could become a frequent call through the cabin intercom in the months … even years to come.

The bottom line implications are obvious.

The response to ‘back-off’ probably has nothing to do with safety and more to do with protecting those executive stock options.

Which brings us to the markets.

Analysis: SPBIO (LABD)

The last update for biotech said it was ‘about to get real’. So, it has.

Looking at SPBIO inverse fund LABD, we have the familiar trend lines:

The market itself says it wants to follow this trend.

Pulling out to the weekly, we get what seems to be an incredible picture.

At the beginning of the trade, the short position in SPBIO, via LABD (not advice, not a recommendation), had an exit time-frame during the second, or third week of October.

From an empirical and seasonal standpoint, that’s when on-going downtrends tend to reach their lows.

Already Baked In:

Various numbers are bandied about as to how many have been injected.

One estimate is 2-Billion, world-wide (Dr. Coleman if memory serves).

Total population at 7.9-Billion; 2-Billion, equates roughly to 25%

No matter what happens, de-population is already baked-in.

Stay Tuned

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

Biotech: Technical Force

2:46 p.m., EST

LABD, Force Index Divergence

Sentiment, Volume, Price

Sentiment can’t be seen on the chart. One can guess but it can’t be measured directly.

Sentiment change comes first.

That change in turn, results in a change of volume, i.e. ‘commitment’.

Then, after commitment dissipates, price is next.

That looks like the current situation with biotech and specifically inverse fund, LABD.

In what may be an idiot or genius move (depending on outcome), the short in biotech SPBIO (via LABD) has been maintained throughout the current down thrust; not advice, not a recommendation.

The reasons for that decision have as many layers as the proverbial onion. Not the least of which, is a market break anywhere from 20% to 50% (in our view) can happen at any moment.

‘Never happened before’, one might say.

Oil futures in their entire history have never gone negative before, either.

Bonds, in their entire history have never been shorted by four-standard deviations before, either.

A world-wide coordinated push to euthanize the entire population has never happened before, either.

Margin debt and valuations have never been higher before, either.

Underlying liquidity has never before been removed to the current extent, either.

So, we each have our own reasons.

The firm’s main account (not the Project Stimulus account) has drawn down about – 13%, on the current short position.

A core position has been maintained but small amounts have been removed and added based on price action.

When the anticipated gain, is high hundreds of percent and maybe above 1,000%, the draw down above, looks acceptable considering the (potential) opportunity.

On to the chart:

The daily chart of LABD, shows both net downward price action and thrust energy are dissipating.

Note the ‘Force Index’ scale has been accentuated to better show the divergence.

We’re looking for price to move back higher to test support/resistance areas.

If or when it does, the plan (as has been from the beginning) is to continue to add LABD until volatility makes it prohibitive.

Stay Tuned

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

Biotech: It’s a Set-Up

12:57 p.m., EST

‘Breakout or Set-Up’ has been resolved

Biotech IBB, posts new daily low.

Going back a few days, we had the chart above:

Price action then stalled, retraced, penetrated support (blue line).

Yesterday, it edged higher in a low-volume test. Today, it reversed again and has just now, posted a new daily low.

It’s high probability the set-up is complete:

The expectation is for biotech IBB (and SPBIO) to decline from here.

Measured move targets have already been discussed as well as Point & Figure targets.

Several times in these updates the word ‘collapse’ has been used to describe the potential for biotech.

The monthly chart below shows a Fibonacci projection based off current price action.

Note how projected levels match up with support and resistance areas:

Obvioulsy, this is a long term projection.

It may work out the short position in biotech via LABD, (not advice not a recommendation) will have to be exited and re-entered several or many times if/when the sector heads for the bottom.

Stay Tuned

Bonus:

The hourly chart of IBB below, shows Wednesday’s price action touching, then bouncing off the first Fibonacci projection.

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

Controlled Insanity

1:32 p.m., EST

It’s not ‘controlled opposition’

It’s controlled insanity

The masses (maybe all of us for that matter) have to be kept on edge just enough to be easily advanced to the next level of narrative.

Case in point, is this link.

It’s just one more piece of pre-programmed trash that’s attempting to control the public’s perception and direction.

“Globalists Losing Narrative”

Give me a break. Globalists aren’t losing anything. At least, not yet.

Markets & SPBIO

The overall markets are still hovering at all time highs; even as reports like this one, continue to show that everybody’s all-in on an unprecedented scale.

Evidently, they have no plan for down … where the real money’s made.

Moderna’s (MRNA) in its second day attempt to breakout higher; all the while, the index itself (SPBIO) continues to edge lower.

The 2-Hour chart of LABD below, shows a potential trend.

As with previous analysis comments, we’re looking for a trend the market itself, says is important:

It’s clear, the trend (above) has been repeated several times in LABD’s own price action.

LABD itself, tells us to pay attention.

The right side trend line might not look like much … but it’s rising at about +45,500%, on an annualized basis.

Positioning:

A break of this trend does not necessarily mean we’ll exit out Project Stimulus position; not advice, not a recommendation.

We’ve got the hard stop discussed previously at LABD 21.77; again, not advice, not a recommendation.

Summary:

While the retail traders/investors (the only direction they know is up) go collectively insane, we’re keeping under the radar and quietly maintaining the short positioning in biotech.

Stay Tuned

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

Lower, Lower … Weaker, Weaker

6:37 p.m., EST

Inverse biotech LABD, closes lower (again).

All is not what is seems.

Down-thrust energy diverging.

The daily close of LABD, shows price action has penetrated another (lower) support level.

Close below support on the weakest down-thrust energy (and lowest volume) since LABD, started its corrective move on May 14th.

Everyone has their own preferred time-frame. Ours is probably longer than most.

If there’s going to be a meltdown in biotech or some kind of serious correction lower, a likely bottom for a sustained move (as said before) will be where they usually are … the third week of October.

Price action is the final arbiter. However, it (SPBIO) has not (yet) indicated it’s on a new bull run to new highs.

At this point, the market’s frustrating both longs and shorts … and doing a good job of it as well.

Our short position via LABD, is being maintained … but the finger is edging closer to the sell button; not advice, not a recommendation.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.